Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Discover various ways to increase your cash back earnings. Enhance your savings potential with these effective strategies.
24,319 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
As Ardent Health closes 2025, the Q4 results shed light on margins, volumes, and balance-sheet health. This analysis ...
Sandisk has surged as AI infrastructure gains grab headlines. But can the rally last? This article lays out 3-year sc...
Q1 2026 dumped new data on the health tech landscape, revealing who’s thriving, where margins are headed, and how to ...
When a specialized media stock falls on earnings day, it’s a signal to dig deeper. This article explains why webtoon ...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Cracker Barrel’s 2026 earnings story hinges on traffic trends, pricing power, and margin discipline. This guide break...
Howard Marks cautions that the AI stock rally may be more speculation than solid analysis, urging investors to anchor...
In 2026, two chip leaders offer very different paths to growth. This guide breaks down how to decide between advanced...
Nvidia stock could reach $250 per share as AI-driven data-center demand accelerates earnings, but regulatory and macr...
The GRID fund has surged about 23% in 2026, outpacing the traditional utilities ETF XLU as AI-enabled grid modernizat...
Wendy’s stock rose in Friday trading on a viral Save Wendy’s meme, extending a three-week rebound despite a challengi...